15 June 2020 – The Hague, The Netherlands. Mellon Medical, a Dutch company focusing on the development of single handed surgical suturing devices, today announced the closing of a new financing round, to further advance the Switch® towards market introduction. The Switch® is a (single patient use) precision surgical suturing device for abdominal wall closure, ideal for enabling the ‘small bites’ technique. This will reduce the risk of complications such as post-surgery incisional hernia, resulting in improved patient outcome and a substantial reduction of healthcare costs.
Along with this agreement Demcon will become a new shareholder in Mellon, contributing to the € 4 million in new development funds together with existing shareholders BioGeneration Ventures, David Pyott, OostNL, Brabantse Ontwikkelings Maatschappij (BOM) and Thuja Capital. Thuja, OostNL and BOM were the founding investors of Mellon Medical.
Please find the full press release here in English and Dutch.